top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147574 bytes
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147532 bytes
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 170622 bytes
Ehjournal

According to baseline CockcroftGault, there were 7518 patients (42%) with an estimated GFR (eGFR) of >80 mL/min, 7587 (42%) between >50 and 80 mL/min, and 3017 (15%) with an eGFR of 50 mL/min. See ...

European Heart Journal, Hohnloser, Stefan H., Hijazi, Ziad, Thomas, Laine, Alexander, John H., Amerena, John, Hanna, Michael, Keltai, Matyas, Lanas, Fernando, Lopes, Renato D., Lopez-Sendon, Jose, ...

Date : 01/11/2012 Item size : 268417 bytes